iCardiac eCOA platform a 'major step forward,' says CEO

By Melissa Fassbender contact

- Last updated on GMT

iCardiac launches new eCOA platform QPoint

Related tags: Technology

iCardiac’s new eCOA platform, QPoint, can measure clinical outcome assessments from patients at home or during site visits and will soon integrate with emerging wearables.

According to the company, study team members can customize study questionnaires and how they appear on devices in real time through its interactive study setup and validation portal RapidStart.

Alex Zapesochny, President and CEO of iCardiac Technologies, told us the platform has a number of technology features that sets it apart from others on the market​.

An important differentiator is our study setup simulator, which enables the eCOA vendor to efficiently and interactively create, review and test a study questionnaire in real time​,” he said. “Another key technology differentiator is the way the platform allows for a seamless study update or device replacement process​.”

Zapesochny explained the platform represents a major step forward for iCardiac, because it completes the company’s goal of to offer enabling innovation across all three of its service lines: cardiac safety​, eCOA, and respiratory testing.

It is also a step forward because, just like iCardiac was able to do in the field of cardiac safety, we believe the QPoint platform will set off a wave of innovation in the eCOA industry that will ultimately benefit all drug developers​,” added Zapesochny.

The company is currently working on the next set of features for QPoint and plans on extending the platform to integrate with emerging wearable and home-based diagnostic devices.

(Feature image: iStock/Rasulovs)

Related news

Show more

Related products

show more


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Related suppliers